Photo via Fast Company
A startup that markets itself as a longevity medicine company is launching what critics are calling the 'Steroid Olympics' this Memorial Day weekend in Las Vegas. According to Fast Company, Enhanced Games will feature 42 elite athletes—including several Olympic medalists—competing in swimming, weightlifting, and running events where approximately 90% of participants openly use performance-enhancing drugs that would be banned at traditional competitions.
Enhanced, which went public in May, has drawn investment from high-profile backers including Donald Trump Jr.'s 1789 Capital and billionaire entrepreneur Peter Thiel. The company positions itself as disrupting sports science through 'direct-to-consumer longevity medicine,' offering participating athletes monthly stipends, coaching, medical oversight, and nutritional support. The event itself carries a $25 million prize pool and will feature a concert headlined by The Killers, with peptides and other performance-enhancing substances available for purchase.
The company operates within a legal gray area by restricting athletes to FDA-approved substances—including human growth hormone, testosterone, and various metabolic modulators—rather than illegal drugs. However, these same substances are banned by the World Anti-Doping Agency and international sports bodies. The International Olympic Committee and WADA have both criticized the event, and athletes participating face potential permanent bans from traditional international competitions.
For Dallas-area healthcare and biotech professionals, the Enhanced Games represent a broader trend in how companies are commercializing sports science and longevity medicine outside traditional regulatory frameworks. The event underscores growing investor appetite for alternative approaches to athletic performance, though it also raises questions about liability, medical ethics, and how the sports industry will respond to competition that openly embraces pharmaceutical enhancement.
